atromid s cap 500mg capsule
ayerst laboratories - clofibrate - capsule - 500mg - clofibrate 500mg - fribic acid derivatives
novo-fibrate cap 500mg capsule
novopharm limited - clofibrate - capsule - 500mg - clofibrate 500mg - fribic acid derivatives
atromid-s cap 500mg capsule
wyeth-ayerst canada inc. - clofibrate - capsule - 500mg - clofibrate 500mg - fribic acid derivatives
atromid-s
astrazeneca limited - clofibrate 500mg - liquid filled capsule - 500 mg - active: clofibrate 500mg excipient: amaranth gelatin glycerol sodium ethyl hydroxybenzoate sodium propyl hydroxybenzoate
clofirem
ebos group ltd - clofibrate 500mg - capsule - 500 mg - active: clofibrate 500mg
liprinal
bristol-myers squibb (nz) limited - clofibrate 500mg - capsule - 500 mg - active: clofibrate 500mg
metchek 500 mg
psm healthcare ltd trading as api consumer brands - metformin hydrochloride 500mg; ; - film coated tablet - 500 mg - active: metformin hydrochloride 500mg excipient: colloidal silicon dioxide hypromellose e-15 macrogol 6000 magnesium stearate maize starch povidone propylene glycol purified talc purified water sodium starch glycolate titanium dioxide - to control hyperglycaemia in metformin responsive, stable, mild, non-ketosis prone maturity onset type of diabetes (type ii) which cannot be controlled by proper dietary management, exercise and weight reduction or when insulin therapy is not appropriate. it may be used alone or in combination with sulphonylurea therapy. metformin can be of value for the treatment of obese diabetics. it may also be used as adjuvant therapy in insulin-dependent diabetics especially if they are overweight.
atromid-s capsules 500 mg
astrazeneca - clofibrate - capsule - 500 mg
prem-clofibrate capsules
the premier pharmaceutical co ltd - capsule - each capsule contains clofibrate 500 mg
tolbutamide tab 500mg tablet
pro doc limitee - tolbutamide - tablet - 500mg - tolbutamide 500mg - sulfonylureas